Results 191 to 200 of about 144,316 (318)

A Randomized, Parallel-Group, Open-Label Trial of Recombinant Human Erythropoietin vs Preoperative Autologous Donation in Primary Total Joint Arthroplasty [PDF]

, 2007
E. Michael Keating, John J. Callaghan, Amar S. Ranawat, Kiran Bhirangi, Chitranjan S. Ranawat   +4 more
openalex   +1 more source

Clonal Progression and Leukemic Transformation of a TP53 Mutated Post‐Polycythaemia Vera Myelofibrosis

European Journal of Haematology, Volume 116, Issue 1, Page 93-97, January 2026.
ABSTRACT Previous studies investigating the role of TP53 mutations in chronic phase MPN have yielded inconsistent results. As such, the clinical relevance of these mutations remains to be elucidated. We report a case of a 67‐year‐old woman with a leukemic transformation of a post‐polycythaemia vera myelofibrosis (post‐PV MF) that culminated in the rare
Isidor Minović, Bart Koopman, Joris J. W. Ploegmakers, Elise M. J. van der Logt, Arjen H. G. Cleven, Anouk van der Veen, Arjan Buijs, André B. Mulder, Emanuele Ammatuna   +8 more
wiley   +1 more source

Erythroferrone, Hepcidin, and Erythropoietin in Chronic Kidney Disease: Associations with Hemoglobin and Renal Function. [PDF]

J Clin Med
Öneç K, Altun G, Özdemir Aytekin Ş, Davran F, Öneç B.   +4 more
europepmc   +1 more source

Chronic inflammation is not associated with attenuated sodium‐glucose co‐transporter 2 inhibitor‐induced hemoglobin increase in patients with diabetes

Journal of Diabetes Investigation, Volume 17, Issue 1, Page 25-33, January 2026.
ABSTRACT Aims/Introduction This study aimed to investigate whether the use of sodium‐glucose co‐transporter 2 inhibitors (SGLT2is) is associated with an increase in hemoglobin in the presence of chronic inflammation. Materials and Methods This is a matched‐pair cohort study.
Miho Murashima, Kodai Suzuki, Takahisa Kasugai, Yuki Miyaguchi, Maki Hiratsuka, Tatsuya Tomonari, Minamo Ono, Masashi Mizuno, Tomohiro Tanaka, Takayuki Hamano   +9 more
wiley   +1 more source

When two signals are better than one: Synergistic control of erythropoiesis. [PDF]

PLoS Biol
Wilson NK.
europepmc   +1 more source

Increased HbA1c relative to actual glycemic control in patients treated with sodium–glucose cotransporter 2 inhibitors

Journal of Diabetes Investigation, Volume 17, Issue 1, Page 34-41, January 2026.
ABSTRACT Aims/Introduction Among patients with diabetes receiving sodium–glucose cotransporter 2 (SGLT2) inhibitors, HbA1c levels are higher than glycated albumin levels. This study therefore aimed to evaluate the discrepancy between HbA1c and glucose management indicator (GMI), an index of glucose management derived from continuous glucose monitoring,
Keigo Mizutani, Eita Uenishi, Takeshi Onoue, Ryutaro Maeda, Koji Suzuki, Tomoko Handa, Tomoko Kobayashi, Shintaro Iwama, Takashi Miyata, Mariko Sugiyama, Daisuke Hagiwara, Hidetaka Suga, Masaki Okazaki, Atsushi Hashizume, Hiroshi Arima   +14 more
wiley   +1 more source

The effect of the erythropoietin resistance index on brain hemorrhage and infarction risk in maintenance hemodialysis patients: a retrospective cohort study. [PDF]

PeerJ
Liu M, Ren K, Wang Q, Zhao C, Ren Z, Bai J, Cao N.   +6 more
europepmc   +1 more source

Erythropoietin alone induces erythroid burst formation by human embryonic but not adult BFU-E in unicellular serum-free culture [see comments] [PDF]

, 1989
M Valtieri, Marco Gabbianelli, E Pelosi, E Bassano, Stefano Petti, G Russo, Ugo Testa, C Peschle   +7 more
openalex   +1 more source

[Retracted] Protective effect of erythropoietin against myocardial injury in rats with sepsis and its underlying mechanisms. [PDF]

Mol Med Rep
Zhang X, Dong S, Qin Y, Bian X.
europepmc   +1 more source

Investigation of the pronounced erythropoietin-induced reduction in hyperglycemia in type 1-like diabetic rats

, 2017
Shu‐Chun Kuo, Yingxiao Li, Kai‐Chun Cheng, Chiang‐Shan Niu, Juei‐Tang Cheng, Ho‐Shan Niu   +5 more
openalex   +2 more sources